Clinical Trials Browser

Phase 1/2 × Recruiting × dexamethasone 21-phosphate × Clear all

NCT06785415 2025-09-30

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

Phase 1/2 Recruiting

Multiple Myeloma